Gout and hyperuricemia in young people

Current Opinion in Rheumatology

Volumn 23, Issue 2, 2011, Pages 156-160

  Yamanaka, Hisashi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

transporter; urate deposition; uric acid

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CARRIER PROTEIN; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 9; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; LRP2 PROTEIN; PROTEIN; RASBURICASE; SLC22A12 PROTEIN; THEOPHYLLINE; UNCLASSIFIED DRUG; URATE TRANSPORTER; URIC ACID; VALPROIC ACID;

ACUTE KIDNEY FAILURE; ACUTE LYMPHOCYTIC LEUKEMIA; ADULTHOOD; AGE DISTRIBUTION; ARTERIAL WALL THICKNESS; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; CHILDHOOD DISEASE; CYANOTIC HEART DISEASE; GASTROENTERITIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GOUT; HUMAN; HYPERURICEMIA; HYPERURICOSURIA; INBORN ERROR OF METABOLISM; INSULIN RESISTANCE; KIDNEY DISEASE; LESCH NYHAN SYNDROME; LINKAGE ANALYSIS; MEDULLARY SPONGE KIDNEY; METABOLIC SYNDROME X; PRIORITY JOURNAL; PURINE METABOLISM; RESPIRATORY TRACT INFECTION; SINGLE DRUG DOSE; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTOPENIC PURPURA; URIC ACID BLOOD LEVEL; URIC ACID NEPHROPATHY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; GOUT; HUMANS; HYPERURICEMIA; MIDDLE AGED; URIC ACID;

EID: 79951580137     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/BOR.0b013e3283432d35     Document Type: Article

References (57)

1. Hernandez-Cuevas CB, Roque LH, Huerta-Sil G. First acute gout attacks commonly precede features of the metabolic syndrome. J Clin Rheumatol 2009; 15:65-67.
2. Zeng QY, Chen R, Darmawan J, et al. Rheumatic diseases in China. Arthritis Res Ther 2008; 10:R17.
3. Weaver AL. Epidemiology of gout. Cleve Clin J Med 2008; 75 (Suppl 5):S9-S12.
4. Tanaka E, Yamanaka H, Shoji A, et al. Recent trend in the onset age of gouty arthritis in Japan. Gout and Nucleic Acid Metabolism 2004; 28: 7-11.
5. Chen SY, Chen CL, Shen ML, Kamatani N. Trends in the manifestations of gout in Taiwan. Rheumatology (Oxford) 2003; 42:1529-1533. (Pubitemid 37521214)
6. Choi HK, Atkinson K, Karlson EW, et al. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med 2004; 350:1093-1103. (Pubitemid 38298989)
7. Choi HK, Liu S, Curhan G. Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 2005; 52:283-289. (Pubitemid 40129260)
8. Choi JW, Ford ES, Gao X, Choi HK. Sugar-sweetened soft drinks, diet soft drinks, and serum uric acid level: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 2008; 59:109-116. (Pubitemid 351171885)
9. Choi HK, Curhan G. Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study. BMJ 2008; 336:309-312. (Pubitemid 351278368)
10. Chiou WK, Wang MH, Huang DH, et al. The relationship between serum uric acid level and metabolic syndrome: differences by sex and age in Taiwanese. J Epidemiol 2010; 20:219-224.
11. Willcox WD. Abnormal serum uric acid levels in children. J Pediatr 1996; 128:731-741.
12. Kubota M. Hyperuricemia in pediatric field. Gout and Nucleic Acid Metabolism •2009; 33:37-43.
13. Hayabuchi Y, Matsuoka S, Akita H, Kuroda Y. Hyperuricaemia in cyanotic congenital heart disease. Eur J Pediatr 1993; 152:873-876. (Pubitemid 23323001)
14. Adler R, Robinson R, Pazdral P, Grushkin C. Hyperuricemia in diarrheal dehydration. Am J Dis Child 1982; 136:211-213. (Pubitemid 12183532)
15. Shimizu T, Morikawa A, Maeda S, et al. Effect of theophylline on serum uric acid levels in children with asthma. J Asthma 1994; 31:387-391. (Pubitemid 24326258)
16. Attilakos A, Voudris KA, Garoufi A, et al. Effect of sodium valproate monotherapy on serum uric acid concentrations in ambulatory epileptic children: a prospective long-term study. Eur J Paediatr Neurol 2006; 10:237-240. (Pubitemid 44804128)
17. Jastaniah WA, Pritchard SL, Wu JK, Wadsworth LD. Hyperuricemia and reticulocytopenia in association with autoimmune hemolytic anemia in two children. Am J Clin Pathol 2004; 122:849-854; PubMed PMID: 1 5539377. (Pubitemid 39577352)
18. Coiffier B, Altman A, Pui CH, et al. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. J Clin Oncol 2008; 26:2767-2778.
19. Nyhan WL. Inherited hyperuricemic disorders. Contrib Nephrol 2005; 147:22-34. (Pubitemid 43264982)
20. De Gemmis P, Anesi L, Lorenzetto E, et al. Analysis of the HPRT1 gene in 35 Italian Lesch-Nyhan families: 45 patients and 77 potential female carriers. Mutat Res 2010; 692:1-5.
21. Garcia MG, Torres RJ, Puig JG. Methylation status of HPRT1 promoter in HPRT deficiency with normal coding region. Nucleosides Nucleotides Nucleic Acids 2010; 29:301-305.
22. Torres RJ, Garcia MG, Puig JG. Partial HPRT deficiency phenotype and incomplete splicing mutation. Nucleosides Nucleotides Nucleic Acids 2010; 29:295-300.
23. Jinnah HA, Ceballos-Picot I, Torres RJ, et al. Lesch-Nyhan Disease International Study Group. Attenuated variants of Lesch-Nyhan disease. Brain 2010; 133 (Pt 3):671-689.
24. Hladnik U, Nyhan WL, Bertelli M. Variable expression of HPRT deficiency in 5 members of a family with the same mutation. Arch Neurol 2008; 65:1240-1243.
25. Garća MG, Torres RJ, Prior C, Puig JG. Normal HPRT coding region in complete and partial HPRT deficiency. Mol Genet Metab 2008; 94:167-172.
26. Ea HK, Bardin T, Jinnah HA, et al. Severe gouty arthritis and mild neurologic symptoms due to F199C, a newly identified variant of the hypoxanthine guanine phosphoribosyltransferase. Arthritis Rheum 2009; 60:2201-2204.
27. Roche A, Perez-Duenas B, Camacho JA, et al. Efficacy of rasburicase in hyperuricemia secondary to Lesch-Nyhan syndrome. Am J Kidney Dis 2009; 53:677-680.
28. Hobbs DJ, Steinke JM, Chung JY, et al. Rasburicase improves hyperuricemia in infants with acute kidney injury. Pediatr Nephrol 2010; 25:305-309; Epub 2009 Nov 21.
29. Zhang W, Bao CD, Gu YY, Ye S. Glycogen storage disease manifested as gout and myopathy: three case reports and literature review. Clin Rheumatol 2008; 27:671-674.
30. Kamatani N, Yamanaka H, Totokawa S, et al. Down syndrome with coexistent gout: report of six patients and possible reasons for the scarcity of descriptions of this association. Ann Rheum Dis 1996; 55:649-650. (Pubitemid 26316285)
31. Kamatani N, Moritani M, Yamanaka H, et al. Localization of a gene for familial juvenile hyperuricemic nephropathy causing underexcretion-type gout to 16p12 by genome-wide linkage analysis of a large family. Arthritis Rheum 2000; 43:925-929.
32. Hart TC, Gorry MC, Hart PS, et al. Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyper-uricaemic nephropathy. J Med Genet 2002; 39:882-892. (Pubitemid 36009149)
33. Bleyer AJ, Gupta K. UMOD-related kidney disease. In: Pagon RA, Bird TC, Dolan CR, Stephens K, editors. Gene reviews [Internet]. Seattle, Washington: University of Washington, Seattle; 1993.2007 Jan 12 [updated 26 September 2007].
34. Choi HK, Zhu Y, Mount DB. Genetics of gout. Curr Opin Rheumatol 2010; 22:144-151.
35. Stark K, Reinhard W, NeureutherK, et al. Association of common polymorphisms in GLUT9 gene with gout but not with coronary artery disease in a large case-control study. PLoS One 2008; 3:e1948.
36. Li S, Sanna S, Maschio A, et al. The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts. PLoS Genet 2007; 3:e1-94.
37. Urano W, Taniguchi A, Anzai N, et al. Association between GLUT9 and gout in Japanese men. Ann Rheum Dis 2010; 69:932-933.
38. Phipps-Green AJ, Hollis-Moffatt JE, Dalbeth N, et al. A strong role for the ABCG2 gene in susceptibility to gout in New Zealand Pacific Island and Caucasian, but not Maori, case and control sample sets. Hum Mol Genet 2010; 19:4813-4819.
39. Yamagishi K, Tanigawa T, Kitamura A, et al., CIRCS Investigators. The rs2231142 variant of the ABCG2 gene is associated with uric acid levels and gout among Japanese people. Rheumatology (Oxford) 2010; 49:1461-1465.
40. Matsuo H, Takada T, Ichida K, et al. Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population. Sci Transl Med 2009; 1:5-11.
41. Wang B, Miao Z, Liu S, et al. Genetic analysis of ABCG2 gene C421A polymorphism with gout disease in Chinese Han male population. Hum Genet 2010; 127:245-246.
42. Woodward OM, Kottgen A, Coresh J, etal. Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc Natl Acad Sci USA 2009; 106:10338-10342.
43. Kolz M, Johnson T, Sanna S, et al. Meta-analysis of 28141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet 2009; 5:e1000504.
44. Dehghan A, Kottgen A, Yang Q, et al. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet 2008; 372:1953-1961.
45. Kamatani Y, Matsuda K, Okada Y, et al. Genome-wide association study of hematological and biochemical traits in a Japanese population. Nat Genet 2010; 42:210-215.
46. Jutabha P, Anzai N, Kitamura K, etal. Human sodium-phosphate transporter 4 (hNPT4/SLC17A3) as a common renal secretory pathway for drugs and urate. J Biol Chem 2010; 285:35123-35132.
47. Brandstatter A, Lamina C, Kiechl S, etal. Sex and age interaction with genetic association of atherogenic uric acid concentrations. Atherosclerosis 2010; 210:474-478.
48. Kaneshi T, Yoshida T, Ohshiro T, et al. Birthweight and risk factors for cardiovascular diseases in Japanese schoolchildren. Pediatr Int 2007; 49:138-143. (Pubitemid 46562429)
49. Franco MC, Christofalo DM, Sawaya AL, etal. Effects of low birth weight in 8-to 13-year-old children: implications in endothelial function and uric acid levels. Hypertension 2006; 48:45-50. (Pubitemid 44297523)
50. Park B, Park E, Cho SJ, et al. The association between fetal and postnatal growth status and serum levels of uric acid in children at 3 years of age. Am J Hypertens 2009; 22:403-408.
51. Fraile JM, Torres RJ, de Miguel ME, etal. Metabolic syndrome characteristics in gout patients. Nucleosides Nucleotides Nucleic Acids 2010; 29:325-329.
52. Denzer C, Muche R, Mayer H, et al. Serum uric acid levels in obese children and adolescents: linkage to testosterone levels and premetabolic syndrome. J Pediatr Endocrinol Metab 2003; 16:1225-1232. (Pubitemid 38016427)
53. Oyama C, Takahashi T, Oyamada M, et al. Serum uric acid as an obesity-related indicator in early adolescence. Tohoku J Exp Med 2006; 209:257-262. (Pubitemid 43905558)
54. Gil-Campos M, Aguilera CM, Cañete R, Gil A. Uric acid is associated with features of insulin resistance syndrome in obese children at prepubertal stage. Nutr Hosp 2009; 24:607-613.
55. Pacifico L, Cantisani V, Anania C, et al. Serum uric acid and its association •• with metabolic syndrome and carotid atherosclerosis in obese children. Eur J Endocrinol 2009; 160:45-52.
56. Togashi K, Masuda H, Iguchi K. Effect of diet and exercise treatment for obese Japanese children on abdominal fat distribution. Res Sports Med 2010; 18:62-70.
57. Muntner P, Srinivasan S, Menke A, et al. Impact of childhood metabolic syndrome components on the risk of elevated uric acid in adulthood: the Bogalusa Heart Study. Am J Med Sci 2008; 335:332-337.